LB Pharmaceuticals Statistics

Total Valuation

LBRX has a market cap or net worth of $372.10 million. The enterprise value is $340.77 million.

Market Cap	372.10M
Enterprise Value	340.77M

Important Dates

The next estimated earnings date is Friday, November 21, 2025, before market open.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

LBRX has 22.44 million shares outstanding. The number of shares has increased by 0.87% in one year.

Current Share Class	22.44M
Shares Outstanding	22.44M
Shares Change (YoY)	+0.87%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.46%
Owned by Institutions (%)	8.28%
Float	12.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	33.82
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.78, with a Debt / Equity ratio of 0.36.

Current Ratio	3.78
Quick Ratio	3.64
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-209.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.84M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, LBRX has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	55.55
Average Volume (20 Days)	131,160

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-32.21M
Pretax Income	-29.43M
Net Income	-29.43M
EBITDA	-31.97M
EBIT	-32.21M
Earnings Per Share (EPS)	-$116.88

Full Income Statement

Balance Sheet

The company has $14.23 million in cash and $3.76 million in debt, giving a net cash position of $10.46 million or $0.47 per share.

Cash & Cash Equivalents	14.23M
Total Debt	3.76M
Net Cash	10.46M
Net Cash Per Share	$0.47
Equity (Book Value)	10.39M
Book Value Per Share	-412.54
Working Capital	10.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.43 million and capital expenditures -$693,000, giving a free cash flow of -$42.13 million.

Operating Cash Flow	-41.43M
Capital Expenditures	-693,000
Free Cash Flow	-42.13M
FCF Per Share	-$1.88

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.87%
Shareholder Yield	-0.87%
Earnings Yield	-8.38%
FCF Yield	-11.99%

Analyst Forecast

The average price target for LBRX is $46.33, which is 179.43% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$46.33
Price Target Difference	179.43%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a